Free shipping on all orders over $ 500

IHMT-MST1-58

Cat. No. M45321

All AbMole products are for research use only, cannot be used for human consumption.

IHMT-MST1-58 Structure
Size Price Availability Quantity
1mg USD 150 In stock
5mg USD 330 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

IHMT-MST1-58 is an orally active, potent and selective inhibitor of STE20-like protein 1 kinase (MST1) with an IC50 value of 23 nM.It can be used in studies related to type 1 or type 2 diabetes.

Chemical Information
Molecular Weight 438.50
Formula C21H22N6O3S
CAS Number 2414484-25-4
Form Solid
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Yun Wu, et al. J Med Chem. Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes

Related Hippo (MST) Products
XMU-MP-1

XMU-MP-1 is a potent and selective Hippo/ MST1/2 inhibitor with IC50 values of 71.1 ± 12.9 nM and 38.1 ± 6.9 nM, respectively.

EMT inhibitor-1

EMT inhibitor-1 is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities.

I3MT-3

I3MT-3 (HMPSNE) is a potent, selective, and cell-membrane permeable inhibitor of 3-Mercaptopyruvate sulfurtransferase (3MST) (IC50=2.7 μM). I3MT-3 is inactive for other H2S/sulfane sulfur-producing enzymes. I3MT-3 targets a persulfurated cysteine residue located in the active site of 3MST.

  Catalog
Abmole Inhibitor Catalog




Keywords: IHMT-MST1-58 supplier, Hippo (MST), inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.